Mycoplasmas have been linked as a cofactor to, AIDS, Gulf War Syndrome, Crohn's Diesease, Chronic Fatigue Syndrome and Fibromyalgia, plus other complex unexplained illnesses.

A synergistic formula of 8 rainforest botanicals traditionally used in South America for their active properties. Some people find this article helpful.

For more information on the individual ingredients in the Myco formula, follow the links provided below to the plant database files in the Tropical Plant Database. Each rainforest botanical in this professional formula has been sustainably harvested in the Amazon Rainforest. Click here to learn more about our rainforest ingredients and wild harvesing methods. This product contains no binders, fillers, or exipients and is 100% finely milled natural plants.

Ingredients: A proprietary blend of mullaca, Brazilian peppertree, anamu, clavillia, macela, fedegoso, picão preto, and uva ursi.

Suggested Use: Take 3 capsules twice daily.

Contraindications: None reported.

Drug Interactions: None reported.

Other Practitioner Observations:

• Several plants in this formula have been documented to reduce blood pressure in animal studies. Individuals with low blood pressure should be monitored for this possible effect.
• All of the plants in this formula have demonstrated antimicrobial (antimycoplasmal, antibacterial, & antimycobacterial) effects in laboratory studies. Supplementing the diet with probiotics and digestive enzymes is advisable when this formula is used for longer than 30 days.

Buy 3 - 5 bottles and receive 5% off!
Buy 6  or more bottles and receive 10% off! 

What are Mycoplasmas?
Mycoplasmas are a specific and unique species of bacteria - the smallest free-living organism known on the planet. The primary differences between mycoplasmas and other bacteria is that bacteria have a solid cell-wall structure and they can grow in the simplest culture media. Mycoplasmas however, do not have a cell wall, and like a tiny jellyfish with a pliable membrane, can take on many different shapes which make them difficult to identify, even under a high powered electron microscope. Mycoplasmas can also be very hard to culture in the laboratory and are often missed as pathogenic causes of diseases for this reason. Learn more....

In 1997, the National Center for Infectious Diseases, Centers for Disease Control and Prevention's journal, Emerging Infectious Diseases, published the article,
Mycoplasmas: Sophisticated, Reemerging, and Burdened by Their Notoriety, by Drs. Baseman and Tully who stated:

"Nonetheless, mycoplasmas by themselves can cause acute and chronic diseases at multiple sites with wide-ranging complications and have been implicated as cofactors in disease. Recently, mycoplasmas have been linked as a cofactor to AIDS pathogenesis and to malignant transformation, chromosomal aberrations, the Gulf War Syndrome, and other unexplained and complex illnesses, including chronic fatigue syndrome, Crohn's disease, and various arthritides."

Extensive clinical research is being performed around the world to further investigate how mycoplasmas contribute to the cause or progression of diseases in people, plants and animals.

Third-Party Published Research
This proprietary Raintree product has not been the subject of any clinical research. A partial listing of the published research on each herbal ingredient in the formula is shown below. Please refer to the plant database files by clicking on the plant names below to see all available documentation and research.

Mullaca (Physalis angulata)
Silva, M. T., et al. “Studies on antimicrobial activity, in vitro, of Physalis angulata L. (Solanaceae) fraction and physalin B bringing out the importance of assay determination.” Mem. Inst. Oswaldo Cruz. 2005 Nov; 100(7): 779-82.
Hwang, J. K., et al. “Anticariogenic activity of some tropical medicinal plants against Streptococcus mutans.” Fitoterapia. 2004 Sep; 75(6): 596-8.
Pietro, R. C., et al. “In vitro antimycobacterial activities of Physalis angulata L.” Phytomedicine 2000; 7(4): 335–38.
Januario, A. H., et al. “Antimycobacterial physalins from Physalis angulata L. (Solanaceae).” Phytother. Res. 2002; 16(5): 445-48.
Hussain, H., et al. “Plants in Kano ethnomedicine; screening for antimicrobial activity and alkaloids.” Int. J. Pharmacol. 1991; 29(1): 51–56.
Ogunlana, E. O., et al. “Investigations into the antibacterial activities of local plants.” Planta Med. 1975; 27: 354.

Brazilian peppertree (Schinus molle)
de Lima, M. R., et al. “Anti-bacterial activity of some Brazilian medicinal plants.” J. Ethnopharmacol. 2005 Dec 12;
Schmourlo, G., et al. “Screening of antifungal agents using ethanol precipitation and bioautography of medicinal and food plants.” J. Ethnopharmacol. 2005 Jan; 96(3): 563-8.
de Melo, Jr., E. J., et al. “Medicinal plants in the healing of dry socket in rats: Microbiological and microscopic analysis.” Phytomedicine. 2002; 9(2): 109–16.
Quiroga, E. N., et al. “Screening antifungal activities of selected medicinal plants.” J. Ethnopharmacol. 2001; 74(1): 89–96.
Martinez, M. J., et al. “Screening of some Cuban medicinal plants for antimicrobial activity.” J. Ethnopharmacol. 1996; 52(3): 171–74.
Gundidza, M., et al. “Antimicrobial activity of essential oil from Schinus molle Linn.” Central African J. Med. 1993; 39(11): 231–34.
El-Keltawi, N., et al. “Antimicrobial activity of some Egyptian aromatic plants.” Herba Pol. 1980; 26(4): 245–50.
Ross, S., et al. “Antimicrobial activity of some Egyptian aromatic plants.” Fitoterapia. 1980; 51: 201–5.

Anamu (Petiveria alliacea)
Kim, S., et al. “Antibacterial and antifungal activity of sulfur-containing compounds from Petiveria alliacea L.” J. Ethnopharmacol. 2005 Oct 13;
Kubec, R., et al. “The lachrymatory principle of Petiveria alliacea.” Phytochemistry. 2003 May; 63(1): 37-40.
Caceres, A., et al. “Plants used in Guatemala for the treatment of protozoal infections. I. Screening of activity to bacteria, fungi and American trypanosomes of 13 native plants.” J. Ethnopharmacol. 1998 Oct; 62(3): 195-202.
Caceres, A., et al. “Plants used in Guatemala for the treatment of dermatophytic infections. I. Screening for antimycotic activity of 44 plant extracts.” J. Ethnopharmacol. 1991; 31(3): 263-76.
Misas, C.A.J., et al. “The biological assessment of Cuban plants. III.” Rev. Cub. Med. Trop. 1979; 31(1): 21–27.
Von Szczepanski, C., et al. “Isolation, structure elucidation and synthesis of an antimicrobial substance from Petiveria alliacea.” Arzneim-Forsch 1972; 22: 1975–.

Clavillia (Mirabilis jalapa)
Bolognesi, A. et al. “Ribosome-inactivating and adenine polynucleotide glycosylase activities in Mirabilis jalapa L. tissues.” J. Biol. Chem. 2002; 277(16) 13709–16.
Dimayuga, R. E., et al. ”Antimicrobial activity of medicinal plants from Baja California Sur (Mexico).” Pharmaceutical Biol. 1998; 36(1): 33–43.
Cammue, B. P., et al. “Isolation and characterization of a novel class of plant antimicrobial peptides from Mirabilis jalapa L. seeds.” J. Biol. Chem. 1992; 267(4): 2228–33.
Caceres, A., et al. “Plants used in Guatemala for the treatment of dermatophytic infections. Screening for antimycotic activity of 44 plant extracts.” J. Ethnophamacol. 1991; 31(3): 263–76.
Kusamba, C., et al. “Antibacterial activity of Mirabilis jalapa seed powder.” J. Ethnopharmacol. 1991; 35(2): 197–99.
Caceres, A., et al. “Screening of antimicrobial activity of plants popularly used in Guatemala for the treatment of dermatomucosal diseases.” J. Ethnopharmacol. 1987; 20(3): 223–37.

Macela (Achyrocline satureoides)
Bettega, J. M., et al. “Evaluation of the antiherpetic activity of standardized extracts of Achyrocline satureioides.” Phytother. Res. 2004; 18(10): 819-23.
Zanon, S. M., et al. “Search for antiviral activity of certain medicinal plants from Cordoba, Argentina.” Rev. Latinoamer. Microbiol. 1999; 41(2): 59–62.
Anesini, C., et al. “Screening of plants used in Argentine folk medicine for antimicrobial activity.” J. Ethnopharmacol. 1993; 39(2): 119–28.
Vargas, V., et al. “Mutagenic and genotoxic effects of aqueous extracts of Achyrocline satureoides in prokaryotic organisms.” Mutat. Res. 1990; 240(1): 13–18.
de Souza, C. P., et al. “Chemoprophylaxis of schistosomiasis: molluscicidal activity of natural products.” An. Acad. Brasil. Cienc. 1984; 56(3): 333–38.

Fedegoso (Cassia occidentalis)
Evans C. E., et al. “Efficacy of some nupe medicinal plants against Salmonella typhi: an in vitro study.” J. Ethnopharmacol. 2002 Apr; 80(1): 21-4.
Samy, R. P., et al. “Antibacterial activity of some folklore medicinal plants used by tribals in Western Ghats of India.” J. Ethnopharmacol. 2000; 69(1): 63–71.
Anesini, C., et al. “Screening of plants used in Argentine folk medicine for antimicrobial activity.” J. Ethnopharmacol. 1993; 39(2): 119–28.
Hussain, H., et al. “Plants in Kano ethomedicine: screening for antimicrobial activity and alkaloids.” Int. J. Pharmacog. 1991; 29(1): 51–6.
Gaind, K. N., et al. “Antibiotic activity of Cassia occidentalis.” Indian J. Pharmacy 1966; 28(9): 248–50.

Picão Preto (Bidens pilosa)
Khan, M. R., et al. “Anti-microbial activity of Bidens pilosa, Bischofia javanica, Elmerillia papuana and Sigesbekia orientalis.” Fitoterapia. 2001; 72(6): 662–65.
Chariandy, C. M., et al. “Screening of medicinal plants from Trinidad and Tobago for antimicrobial and insecticidal properties.” J. Ethnopharmacol. 1999; 64(3): 265–70.
Rabe, T. “Antibacterial activity of South African plants used for medicinal purposes.” J. Ethnopharmacol. 1997; 56(1): 81–7.
van Puyvelde, L., et al. “In vitro inhibition of mycobacteria by Rwandese medicinal plants.” Phytother. Res. 1994; 8(2): 65–9.
Desta, B. “Ethiopian traditional herbal drugs. Part II: Antimicrobial activity of 63 medicinal plants.” J. Ethnopharmacol. 1993; 39(2): 129–39.
Boily, Y., et al. “Screening of medicinal plants of Rwanda (central Africa) for antimicrobial activity.” J. Ethnopharmacol. 1986; 16(1): 1–13.
Bondarenko, A. S., et al. “The antimicrobial properties of the polyacetylene antibiotic phenylheptatriyne.” Mikrobiol. Zh. 1985; 47(2): 81–3.

Uva Ursi (Arctostaphylos uva-ursi)
Kruszewska, H., et al. “Examination of antimicrobial activity of selected non-antibiotic drugs.” Acta Pol. Pharm. 2004 Dec; 61 Suppl: 18-21.
Jahodar, L., et al. “Antimicrobial effect of arbutin and an extract of the leaves of Arctostaphylos uva-ursi in vitro.” Cesk Farm. 1985; 34(5):174-8.
Robertson, J. A., et al. “Effect of carbohydrates on growth of Ureaplasma urealyticum and Mycoplasma hominis.” J. Clin. Microbiol. 1987; 25(1): 160-1.
Newton, M., et al. “Select herbal remedies used to treat common urologic conditions.” Urol Nurs. 2001 Jun; 21(3): 232-4.
Floresne, V., et al. “Microbiological testing of uva ursi species (Formulaes Normales V)” Acta Pharm. Hung. 1984 Jul; 54(4): 170-5.